Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Completed Phase 1 Trials for RG-4733 (DB11870)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028499 (Recurrent Adult Diffuse Small Cleaved Cell Lymphoma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | Treatment |